Cogwear provides a wearable EEG platform that captures high-fidelity brainwave data in real-world settings, enabling applications in neuromarketing, product development, and cognitive research. The technology is validated and ready for commercial deployment with TRL 9.
Cogwear offers an innovative wearable EEG technology that revolutionizes how neurodata is captured and utilized outside clinical settings. The platform combines a lightweight, machine-washable headband with advanced algorithms and an intuitive mobile app to deliver clinical-grade EEG data in real-time. This capability allows companies to measure cognitive and emotional responses during motion, providing deeper insights than traditional surveys and biodata.
Key features:
Cogwear's technology is at Technology Readiness Level 9, indicating that it is fully validated and ready for commercial use. It has been implemented in various industries, including neuromarketing and product development, and has generated over 10,000 datasets from more than 1,250 users. The platform is supported by academic research and partnerships, ensuring its reliability and effectiveness.
Cogwear, Inc. has developed a wearable technology platform that captures clinical-grade electroencephalography (EEG) data outside of traditional laboratory environments. The company's primary product is a comfortable, machine-washable headband constructed from breathable fabric that houses proprietary, nanotechnology-inspired sensors. By integrating these sensors with machine learning and AI-powered algorithms, the device accurately measures, interprets, and reports real-time electrical brain activity to a mobile application. This technology is designed to function effectively even while users are walking, exercising, or performing daily activities, overcoming the motion-related signal distortion typically associated with mobile EEG monitoring.
The company's solution aims to provide individuals, healthcare providers, psychologists, and coaches with actionable insights into cognitive and emotional states. Potential applications span a diverse range of fields, including the management of behavioral health conditions, the early detection of neurodegenerative diseases such as Alzheimer’s, sports safety, and human performance optimization. Cogwear is actively pursuing FDA clearance for various medical applications and collaborates with partners in sectors like neuromarketing and sports protection to leverage its data platform for improved decision-making and safety. Founded in 2018 as a spinout from the University of Pennsylvania, the startup continues to expand its research, development, and manufacturing capabilities to bring these insights to broader professional and consumer markets.